Forte Biosciences, Inc. (FBRX)
33.92
+2.49
(+7.92%)
USD |
NASDAQ |
Apr 17, 16:00
33.70
-0.22
(-0.65%)
After-Hours: 20:00
Forte Biosciences EPS Diluted (Quarterly) : -1.914 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| STAAR Surgical Co. | -0.368 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Agenus, Inc. | -0.301 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1341 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -24.79M |
| Total Expenses (Quarterly) | 24.79M |
| Enterprise Value | 587.73M |
| Earnings Yield | -15.45% |
| Normalized Earnings Yield | -15.45 |